Amylyx Pharmaceuticals Inc Cash Flow Reinvestment Rate
Amylyx Pharmaceuticals Inc cash flow reinvestment rate. Amylyx Pharmaceuticals Inc (AMLX) has a Cash Flow Reinvestment Rate of 1.57x as of December 2023, reinvesting $21.28 Million (capex $356.00K plus investments $20.93 Million) from operating cash flow of $13.55 Million. Explore Amylyx Pharmaceuticals Inc (AMLX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Amylyx Pharmaceuticals Inc (2023–2023)
Cash flow reinvestment rate of Amylyx Pharmaceuticals Inc from 2023 to 2023. Historical reinvestment intensity for Amylyx Pharmaceuticals Inc across 1 annual periods. Explore Amylyx Pharmaceuticals Inc (AMLX) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Amylyx Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (2023–2023)
Amylyx Pharmaceuticals Inc cash flow reinvestment rate by year from 2023 to 2023. Year-by-year capital reinvestment analysis for Amylyx Pharmaceuticals Inc. For the full cash flow conversion analysis, see AMLX cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 13.28x | $158.29 Million | $11.92 Million | $1.24 Million | — |